Fri, October 4, 2024
AUS Edition NZ Edition UK Edition CA Edition USA Edition FRA Edition GER Edition ESP Edition ITA Edition NLD Edition
PRT Edition SWE Edition GRC Edition IND Edition POL Edition BRA Edition ZAF Edition RUS Edition CHN Edition UAE Edition
Kalkine Media ASX Share Market News & Research
Kalkine Media ASX Share Market News & Research
  1. Home
  2. Companies
  3. OMIC
Healthcare
Facebook Twitter Linkedin

Singular Genomics Systems Inc (NASDAQ:OMIC)

15.2006 USD

-0.199 1.295%
Last Updated at: 2024-10-03T18:34:00Z

Singular Genomics Systems Inc

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

3010 Science Park Road, San Diego, CA, United States, 92121

858 333 7830

https://singulargenomics.com

Employees: 255

Key Executives

Sr. No. Name Title Year Born
1. Mr. Andrew Spaventa Founder, CEO, Pres & Chairperson of the Board 1985
2. Dr. David L. Barker Ph.D. Founder, Member of Scientific Advisory Board & Independent Director 1942
3. Ms. Daralyn Durie Gen. Counsel 1968
4. Dr. Eli N. Glezer Ph.D. Founder, Chief Scientific Officer & Chair of Scientific Advisory Board 1969
5. Mr. Dalen Meeter Sr. VP of Fin. & CFO 1978
6. Mr. Jorge Velarde Jr., MBA Sr. VP of Corp. Devel. & Strategy 1967
7. Mr. Jeff Bullard Head of Sales NA
8. Mr. Vincent Brancaccio Sr. VP of HR 1983
9. Mr. Andrew Spaventa Founder, CEO, President & Chairperson of the Board 1985
10. Mr. Dalen Meeter Chief Financial Officer 1978

Peers

Sector: Healthcare

Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE(x) Forward PE(x) Price Sales TTM(x) Price to Book Value(x) Enterprise Value to Revenue(x) Enterprise Value to EBITDA(x)
ISRG

Intuitive Surgical Inc

 -6.190 1.272% 484.42 73.050 61.728 19.145 10.247 18.408 59.920
ESLOY

Essilor International SA

 -2.320 1.986% 115.36 35.390 24.814 3.630 2.204 3.996 16.255
ESLOF

EssilorLuxottica Société anonyme

 -2.700 1.160% 230.04 35.710 25.126 3.623 2.229 3.995 16.251
BDX

Becton Dickinson and Company

 -1.405 0.586% 239.16 47.650 17.513 3.595 2.692 4.331 19.058

Income Statement

(Currency in USD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019
Income Before Tax -90.879M -98.771M -27.945M -12.324M
Minority Interest - - - -
Net Income -88.271M -98.889M -28.663M -12.341M
Selling General Administrative 47.264M 28.624M 6.287M 2.286M
Gross Profit -0.024M - - -
Reconciled Depreciation 6.032M 1.133M 0.639M 0.35M
Ebit -93.487M -61.279M -27.534M -12.77M
Ebitda -90.116M -60.546M -26.39M -11.957M
Depreciation And Amortization 3.371M 0.733M 1.144M 0.813M
Operating Income -93.487M -61.279M -27.534M -12.77M
Other Operating Expenses 94.252M 61.279M 27.534M 12.77M
Interest Expense 0.763M 0.846M 0.718M 0.017M
Tax Provision - - - -
Interest Income 3.371M 0.328M 0.505M 0.463M
Net Interest Income 2.608M -0.518M -0.213M 0.446M
Income Tax Expense -2.608M 0.118M 0.718M 0.017M
Total Revenue 0.765M 0M 0M 0M
Total Operating Expenses 93.463M 61.279M 27.534M 12.77M
Cost Of Revenue 0.789M - - -
Total Other Income Expense Net 2.608M -37.492M -0.411M 0.446M
Net Income From Continuing Ops -90.879M -63.572M -27.945M -12.324M
Net Income Applicable To Common Shares -90.879M -98.771M -27.945M -12.324M

Balance Sheet

(Currency in USD)
Breakdown 31-12-2023 31-12-2022 31-12-2021 31-12-2020 31-12-2019
Total Assets 265.467M 327.975M 355.648M 30.502M 48.174M
Intangible Assets - - - - -
Other Current Assets 1.459M 4.722M 4.476M 0.652M 0.261M
Total Liab 86.461M 67.654M 19.475M 82.057M 72.899M
Total Stockholder Equity 179.006M 260.321M 336.173M -51.555M -24.725M
Other Current Liab 1.857M 4.696M 4.396M 0.745M 0.551M
Common Stock 0.007M 0.007M 0.007M 0.001M 0.001M
Capital Stock 0.007M 0.007M 0.007M 0.001M 0.001M
Retained Earnings -337.595M -242.775M -151.896M -53.125M -25.18M
Good Will - - - - -
Other Assets - 2.863M 1.816M 0.563M 0.104M
Cash 16.233M 74.266M 201.049M 11.688M 5.5M
Cash And Equivalents - - - - -
Total Current Liabilities 18.287M 14.118M 6.744M 3.69M 1.112M
Current Deferred Revenue 6.079M - - 1.592M -
Net Debt 59.055M -15.422M -191.145M -2.293M -3.1M
Short Term Debt 7.764M 6.323M - 0.926M -
Short Long Term Debt - - - 0.926M -
Short Long Term Debt Total 75.288M 58.844M 9.904M 9.395M 2.4M
Other Stockholder Equity 516.439M 503.926M 132.552M 1.552M 0.44M
Property Plant Equipment - 10.784M 6.072M 2.368M 1.613M
Total Current Assets 192.228M 268.432M 347.76M 27.571M 46.457M
Long Term Investments - - - - -
Short Term Investments 157.708M 170.31M 138.174M 15.231M 40.696M
Net Receivables 1.584M 0.913M 1.05M 0.017M -
Long Term Debt 8.901M 10.065M 9.904M 8.469M 2.4M
Inventory 13.572M 18.221M 3.011M - -
Accounts Payable 2.587M 3.099M 2.348M 0.427M 0.561M
Accumulated Other Comprehensive Income 0.155M -0.837M -0.138M 0.017M 0.014M
Non Currrent Assets Other 1.75M 2.863M 1.816M 0.563M 0.104M
Non Current Assets Total 73.239M 59.543M 7.888M 2.931M 1.717M
Capital Lease Obligations 66.387M 48.779M - - -
Long Term Debt Total - 10.065M 9.904M - -

Cash Flow

(Currency in USD)
Breakdown 31-12-2022 31-12-2021 31-12-2020 31-12-2019
Investments -33.544M -125.997M 25.385M -30.7M
Total Cashflows From Investing Activities -39.566M -130.861M 24.005M -31.5M
Total Cash From Financing Activities 0.901M 372.128M 7.515M 47.304M
Net Income -90.879M -98.771M -27.945M -12.324M
Change In Cash -125.759M 189.566M 6.647M 4.405M
Begin Period Cash Flow 201.736M 12.17M 5.523M 1.118M
End Period Cash Flow 75.977M 201.736M 12.17M 5.523M
Total Cash From Operating Activities -87.094M -51.701M -24.873M -11.399M
Depreciation 6.032M 1.133M 0.639M 0.35M
Other Cashflows From Investing Activities - - - -
Dividends Paid - 3.577M - -
Change To Inventory -13.487M -13.487M -13.487M -13.487M
Sale Purchase Of Stock -0.45M 3.577M -0.03M -
Other Cashflows From Financing Activities 1.18M 141.752M 7.498M 47.263M
Capital Expenditures 6.022M 4.864M 1.38M 0.8M
Change In Working Capital -16.817M -2.911M 0.858M 0.415M
Other Non Cash Items 0.901M 35.478M 0.234M -0.01M
Free Cash Flow -93.116M -56.565M -26.253M -12.199M

Funds

Sr. No. Name Purchased On Shares
1. Vanguard Total Stock Mkt Idx Inv 5 months ago 1180133
2. Vanguard Institutional Extnd Mkt Idx Tr 5 months ago 649099
3. Fidelity Extended Market Index 6 months ago 247401
4. BlackRock Advantage Small Cap Core Instl 5 months ago 130459
5. iShares Micro-Cap ETF 5 months ago 121370
6. Bridgeway Ultra-Small Company Market 6 months ago 107600
7. Fidelity Total Market Index 6 months ago 78330
8. Christopher Weil & Co Core Investment 6 months ago 66696
9. Fidelity Series Total Market Index 6 months ago 59283
10. NT Ext Equity Mkt Idx Fd - NL 6 months ago 38487
11. NT Ext Equity Mkt Idx Fd - L 6 months ago 38201
12. Northern Trust Extended Eq Market Idx 6 months ago 38201
13. Fidelity Nasdaq Composite Index 6 months ago 37412
14. JPMorgan Small Cap Sustainable Ldrs R5 6 months ago 36852
15. NT Ext Equity Mkt Idx Fd - DC - NL - T2 9 months ago 30910
16. BlackRock Extended Mkt Composite 1 year ago 29725
17. Vanguard Balanced Index Inv 5 months ago 26684
18. Spartan Total Market Index Pool E 6 months ago 25980
19. BlackRock Extended Equity Market K 6 months ago 25942
20. LUX IM Global Medtech HX 5 months ago 18700

Institutions

Sr. No. Name Purchased On Shares
1. ARCH VENTURE CORP 6 months ago 3798926
2. QVIDTVM Management LLC 6 months ago 2506695
3. UBS Group AG 9 months ago 2209350
4. Perceptive Advisors LLC 6 months ago 2126893
5. FMR Inc 9 months ago 2119635
6. Vanguard Group Inc 6 months ago 1872582
7. Casdin Capital, LLC 9 months ago 1323885
8. Bank of Montreal 9 months ago 982499
9. BMO Capital Markets Corp. 9 months ago 982499
10. BlackRock Inc 9 months ago 833595
11. Orbimed Advisors, LLC 6 months ago 540697
12. Verition Fund Managegment, LLC 6 months ago 500000
13. Geode Capital Management, LLC 9 months ago 460639
14. HighTower Advisors, LLC 9 months ago 418322
15. Tikvah Management LLC 6 months ago 316854
16. Hongkou Capital LP 6 months ago 194731
17. Millennium Management LLC 6 months ago 176000
18. Renaissance Technologies Corp 9 months ago 151450
19. Weil Company Inc 9 months ago 138202
20. Bridgeway Capital Management, LLC 6 months ago 121500
Disclaimer

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Related Articles

Code Price Chg %Chg
View All
Code Price Chg %Chg
View All
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Open in the App